Illumina Inc. has introduced PromoterAI, a deep learning algorithm that identifies disease-causing regulatory variants in the noncoding regions of the human genome—specifically promoter regions. This innovation is poised to significantly improve rare disease diagnosis rates, especially where traditional exome sequencing falls short. The Diagnostic Challenge: Unseen Variants in Noncoding DNA 1. Current Limitations in Rare…
Infosys, a global leader in digital services and consulting, has introduced over 200 enterprise AI agents. These agents, powered by Infosys Topaz™ and Google Cloud’s Vertex AI platform, are built to manage complex workflows, enable autonomous decision-making, and improve business operations across industries.
New Relic Integrates AI-Powered GitHub Copilot Coding Agent to Revolutionize Software Development
A new global study by Kyndryl (NYSE: KD), a leading provider of enterprise technology services, uncovers a significant gap between AI investments and workforce readiness. The People Readiness Report, based on a survey of over 1,000 senior executives across 25 industries and eight geographies, finds that only a small number of organizations have aligned their workforce strategies with the growth of AI technology—giving those that have a competitive edge.
Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced the launch of the Viz Oncology™ Suite — a transformative AI platform designed to accelerate access to life-saving cancer care. This marks a strategic extension of Viz.ai’s success beyond stroke, cardiology, respiratory, and radiology into oncology.
